Menu
Back to User profile » Prof. Dr. Myron R. Szewczuk
Papers published by Prof. Dr. Myron R. Szewczuk:
Novel Molecular Mechanism of Aspirin and Celecoxib Targeting Mammalian Neuraminidase-1 Impedes Epidermal Growth Factor Receptor Signaling Axis and Induces Apoptosis in Pancreatic Cancer Cells
Qorri B, Harless W, Szewczuk MR
Drug Design, Development and Therapy 2020, 14:4149-4167
Published Date: 8 October 2020
A Triple Combination of Metformin, Acetylsalicylic Acid, and Oseltamivir Phosphate Impacts Tumour Spheroid Viability and Upends Chemoresistance in Triple-Negative Breast Cancer
Sambi M, Samuel V, Qorri B, Haq S, Burov SV, Markvicheva E, Harless W, Szewczuk MR
Drug Design, Development and Therapy 2020, 14:1995-2019
Published Date: 25 May 2020
Impact of Fucosylation on Self-Assembly of Prostate and Breast Tumor Spheroids by Using Cyclo-RGDfK(TPP) Peptide and Image Object Detection
Kalaydina RV, Zhou H, Markvicheva E, Burov SV, Zulkernine F, Szewczuk MR
OncoTargets and Therapy 2019, 12:11153-11173
Published Date: 17 December 2019
The crucial role of primary care providers in the long-term follow-up of adult survivors of childhood cancer
Jain J, Qorri B, Szewczuk MR
Cancer Management and Research 2019, 11:3411-3418
Published Date: 23 April 2019
Recent advances in "smart" delivery systems for extended drug release in cancer therapy
Kalaydina RV, Bajwa K, Qorri B, Decarlo A, Szewczuk MR
International Journal of Nanomedicine 2018, 13:4727-4745
Published Date: 20 August 2018
Therapeutic potential of medicinal marijuana: an educational primer for health care professionals
Mouhamed Y, Vishnyakov A, Qorri B, Sambi M, Frank SMS, Nowierski C, Lamba A, Bhatti U, Szewczuk MR
Drug, Healthcare and Patient Safety 2018, 10:45-66
Published Date: 11 June 2018
Combinatorial and sequential delivery of gemcitabine and oseltamivir phosphate from implantable poly(D,L-lactic-co-glycolic acid) cylinders disables human pancreatic cancer cell survival
Allison Logan S, Brissenden AJ, Szewczuk MR, Neufeld RJ
Drug Design, Development and Therapy 2017, 11:2239-2250
Published Date: 31 July 2017
Sialylation facilitates self-assembly of 3D multicellular prostaspheres by using cyclo-RGDfK(TPP) peptide
Haq S, Samuel V, Haxho F, Akasov R, Leko M, Burov SV, Markvicheva E, Szewczuk MR
OncoTargets and Therapy 2017, 10:2427-2447
Published Date: 4 May 2017
Alternative therapies for metastatic breast cancer: multimodal approach targeting tumor cell heterogeneity
Sambi M, Haq S, Samuel V, Qorri B, Haxho F, Hill K, Harless W, Szewczuk MR
Breast Cancer: Targets and Therapy 2017, 9:85-93
Published Date: 28 February 2017
Folic acid-conjugated amphiphilic alternating copolymer as a new active tumor targeting drug delivery platform
Li X, Szewczuk MR, Malardier-Jugroot C
Drug Design, Development and Therapy 2016, 10:4101-4110
Published Date: 15 December 2016
Therapeutic designed poly (lactic-co-glycolic acid) cylindrical oseltamivir phosphate-loaded implants impede tumor neovascularization, growth and metastasis in mouse model of human pancreatic carcinoma
Hrynyk M, Ellis JP, Haxho F, Allison S, Steele JAM, Abdulkhalek S, Neufeld RJ, Szewczuk MR
Drug Design, Development and Therapy 2015, 9:4573-4586
Published Date: 10 August 2015
Oseltamivir phosphate monotherapy ablates tumor neovascularization, growth, and metastasis in mouse model of human triple-negative breast adenocarcinoma
Haxho F, Allison S, Alghamdi F, Brodhagen L, Kuta VE, Abdulkhalek S, Neufeld RJ, Szewczuk MR
Breast Cancer: Targets and Therapy 2014, 6:191-203
Published Date: 9 December 2014
Therapeutic targeting of Neu1 sialidase with oseltamivir phosphate (Tamiflu®) disables cancer cell survival in human pancreatic cancer with acquired chemoresistance
O’Shea LK, Abdulkhalek S, Allison S, Neufeld RJ, Szewczuk MR
OncoTargets and Therapy 2014, 7:117-134
Published Date: 16 January 2014
A novel G-protein-coupled receptor-signaling platform and its targeted translation in human disease
Abdulkhalek S, Hrynyk M, Szewczuk MR
Research and Reports in Biochemistry 2013, 3:17-30
Published Date: 7 January 2013